Abbott India Limited vs Pfizer Limited
An objective side-by-side of ABBOTINDIA and PFIZER, both in Pharmaceuticals - Multinational: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
Prices as of 2026-09-21 close
Latest results: ABBOTINDIA Dec 2025 · PFIZER Mar 2026
At a glance
- Abbott India Limited is the larger company by market value, about 3.1 times the size of Pfizer Limited.
- On trailing earnings, Pfizer Limited trades at the lower P/E (25.5 against 39.6).
- Abbott India Limited earns the higher return on equity (30.3% against 17.2%).
- Over the past year the share prices returned -12.8% (ABBOTINDIA) and -21.8% (PFIZER).
| Metric | Abbott India ABBOTINDIA |
Pfizer PFIZER |
|---|---|---|
| Size and price | ||
| Market cap | ₹57,288 Cr | ₹18,462 Cr |
| Share price | ₹26,960 | ₹4,036 |
| Valuation | ||
| P/E | 39.64 | 25.54 |
| P/B | 12.00 | 4.39 |
| EV/EBITDA | 33.34 | 20.50 |
| PEG | — | 3.19 |
| Dividend yield | — | 1.9% |
| Profitability | ||
| ROE | 30.3% | 17.2% |
| ROCE | 45.0% | 24.0% |
| Operating margin | 26.4% | 35.9% |
| Sales (TTM) | ₹6,524 Cr | ₹2,519 Cr |
| Net profit (TTM) | ₹1,445 Cr | ₹723 Cr |
| Growth | ||
| Latest quarter sales YoY | — | +6.2% |
| Latest quarter profit YoY | — | -39.6% |
| Sales CAGR 3Y | — | +1.0% |
| Profit CAGR 3Y | — | +8.0% |
| Sales CAGR 5Y | — | +2.0% |
| Profit CAGR 5Y | — | +9.0% |
| Financial strength | ||
| Debt/Equity | 0.04 | 0.02 |
| Interest cover | — | 94.11 |
| Ownership | ||
| Promoter holding | 75.0% | 63.9% |
| Promoter change (4 qtrs) | +0.00 pp | +0.00 pp |
| Price performance | ||
| Return 1M | +3.22% | -17.97% |
| Return 3M | +3.43% | -9.58% |
| Return 1Y | -12.78% | -21.83% |
| Return YTD | -7.11% | -19.09% |
| Technical condition | ||
| Technical score | 75 | 14 |
| RS rating (1-99) | 50.00 | 24.00 |
| % vs 200-DMA | -0.07% | -14.95% |
| RSI (14) | 57.51 | 21.09 |
| % from 52-week high | -14.02% | -27.66% |
